Bicara Therapeutics Vs. Simulations Plus Industry Stock Comparison

Buy

58

BCAX
Bicara Therapeutics

Last Price:

$13.05

Seasonality Move:

--

Sell

37

SLP
Simulations Plus

Last Price:

$31.09

Seasonality Move:

3.81%

Buy

58

Bicara Therapeutics (BCAX) is a Buy

Is Bicara Therapeutics a Buy, Sell or Hold?

The current Bicara Therapeutics [BCAX] share price is $14.19. The Score for BCAX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

37

Simulations Plus (SLP) is a Sell

Is Simulations Plus a Buy, Sell or Hold?

The current Simulations Plus [SLP] share price is $30.82. The Score for SLP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
SLP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

The Bicara Therapeutics share price today is $14.19

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SLP Stock Price Chart

What is Simulations Plus's stock price today?

The Simulations Plus share price today is $30.82

The current trend is relatively stagnant and SLP is experiencing slight selling pressure.

BCAX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.21	Buy
Relative Strength Index (14 RSI):	55.19	Buy
Chaikin Money Flow:	315501	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(11 - 14.7)	Buy
Bollinger Bands (100):	(11.57 - 15.81)	Buy

SLP Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.32	Buy
Relative Strength Index (14 RSI):	48.64	Sell
Chaikin Money Flow:	-12783	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(28.29 - 35.31)	Sell
Bollinger Bands (100):	(26.51 - 34.15)	Buy

BCAX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	13.51	Buy
20-day SMA:	13.55	Buy
50-day SMA:	13.08	Buy
200-day SMA:	0	Buy
8-day EMA:	13.5	Buy
20-day EMA:	13.38	Buy
50-day EMA:	13.28	Buy
200-day EMA:	11.72	Buy

SLP Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	31.2	Sell
20-day SMA:	33.1	Sell
50-day SMA:	28.9	Buy
200-day SMA:	31.75	Sell
8-day EMA:	31.15	Sell
20-day EMA:	31.45	Sell
50-day EMA:	30.59	Buy
200-day EMA:	32.65	Sell

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.00 per share, and a decrease next year of $0.52 per share.

Simulations Plus Earnings Growth & SLP Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.11 per share, an increase this year of $0.56 per share, and an increase next year of $0.14 per share.

Bicara Therapeutics Technical Analysis

	Apr 29	Apr 30	May 1	May 2	May 5	May 6	May 7	May 8	May 9	May 12
	Apr			May
	29	30	01	02	05	06	07	08	09	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Simulations Plus Technical Analysis

	Apr 29	Apr 30	May 1	May 2	May 5	May 6	May 7	May 8	May 9	May 12
	Apr			May
	29	30	01	02	05	06	07	08	09	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):